Solifenacin induced dyskinesia
Ersel Dağ 1 * , Burcu Azapoğlu, Turgut Deniz
More Detail
1 Kırıkkale University, Department of Neurology, Kırıkkale, Turkey* Corresponding Author


Overactive bladder syndrome is a chronic condition characterised by urgency, with or without associated urge incontinence. Solifenacin succinate is a once daily, bladder selective antimuscarinic available. The recommended dose is 5 mg once daily and can be increased to 10 mg once daily if 5 mg is well tolerated. We report here a case with dyskinesia emerged following the use of solifenacin, and disappeared in a few days with stopping the agent.


This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Article Type: Case Report

J Clin Exp Invest, 2012, Volume 3, Issue 4, 539-540

Publication date: 13 Dec 2012

Article Views: 2318

Article Downloads: 1147

Open Access References How to cite this article